(Q43738139)

English

Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53. (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

Zhang LH

1

1 reference

Europe PubMed Central

26 November 2017

Youn HD

2

1 reference

Europe PubMed Central

26 November 2017

Liu JO

3

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

13 September 2001

1 reference

Europe PubMed Central

26 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

26 November 2017

276

1 reference

Europe PubMed Central

26 November 2017

47

1 reference

Europe PubMed Central

26 November 2017

43534-43540

1 reference

Europe PubMed Central

26 November 2017

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

FK506 and cyclosporin, molecular probes for studying intracellular signal transduction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Signal transmission between the plasma membrane and nucleus of T lymphocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Immunopharmacology of rapamycin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Manipulating immune responses with immunosuppressive agents that target NFAT.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

A simple technique for quantitation of low levels of DNA damage in individual cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Compromised HOXA5 function can limit p53 expression in human breast tumours

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Nuclear factor - kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

The complexity of p53 modulation: emerging patterns from divergent signals

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

The mechanism of action of FK-506 and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110. I. Taxonomy, Fermentation, Isolation and Biological Activity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. II. Structure elucidation, stereochemistry and physico-chemical properties

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Phorbol ester stimulates the phosphorylation of rabbit erythrocyte band 4.1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104257200

21 January 2018

Identifiers

10.1074/JBC.M104257200

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43738139&oldid=2102941372"